Item Type | Name |
Academic Article
|
Chemotherapy of malignant pleural mesothelioma.
|
Academic Article
|
Current status of screening for malignant pleural mesothelioma.
|
Academic Article
|
Feasibility of immunotherapy for lymphangioleiomyomatosis.
|
Academic Article
|
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
|
Academic Article
|
Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model.
|
Academic Article
|
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy.
|
Academic Article
|
Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.
|
Academic Article
|
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.
|
Academic Article
|
Germline BAP1 mutations predispose to malignant mesothelioma.
|
Academic Article
|
Ranpirnase Interferes with NF-?B Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth.
|
Academic Article
|
Cancer and inflammation: promise for biologic therapy.
|
Academic Article
|
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.
|
Academic Article
|
Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.
|
Academic Article
|
Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes.
|
Academic Article
|
CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
|
Academic Article
|
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
|
Academic Article
|
BAP1 and cancer.
|
Academic Article
|
Simian virus 40 transformation, malignant mesothelioma and brain tumors.
|
Academic Article
|
Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
|
Academic Article
|
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
|
Academic Article
|
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
|
Academic Article
|
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.
|
Academic Article
|
Fowlpox-based survivin vaccination for malignant mesothelioma therapy.
|
Academic Article
|
Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors.
|
Academic Article
|
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
|
Academic Article
|
BAP1 hereditary cancer predisposition syndrome: a case report and review of literature.
|
Academic Article
|
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
|
Academic Article
|
High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.
|
Academic Article
|
Recent insights emerging from malignant mesothelioma genome sequencing.
|
Academic Article
|
Preclinical development of HIvax: Human survivin highly immunogenic vaccines.
|
Academic Article
|
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
|
Academic Article
|
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
|
Academic Article
|
Familial skin cancer syndromes: Increased melanoma risk.
|
Academic Article
|
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
|
Academic Article
|
Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.
|
Academic Article
|
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
|
Academic Article
|
Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
|
Academic Article
|
Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity.
|
Academic Article
|
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
|
Academic Article
|
Improving the Accuracy of Mesothelioma Diagnosis in China.
|
Academic Article
|
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.
|
Academic Article
|
Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression.
|
Academic Article
|
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
|
Academic Article
|
Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China.
|
Academic Article
|
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model.
|
Academic Article
|
Malignant Mesothelioma: Time to Translate?
|
Academic Article
|
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.
|
Academic Article
|
Progress in the Management of Malignant Pleural?Mesothelioma in 2017.
|
Academic Article
|
BAP1 regulates different mechanisms of cell death.
|
Academic Article
|
Does Chromothripsis Make Mesothelioma an Immunogenic Cancer?
|
Academic Article
|
Improving the Accuracy of?Mesothelioma Diagnosis in China.
|
Academic Article
|
Scientific Advances and New Frontiers in Mesothelioma Therapeutics.
|
Academic Article
|
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
|
Academic Article
|
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.
|
Academic Article
|
Coronaviruses: Facts, Myths, and Hypotheses.
|
Academic Article
|
Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
|
Academic Article
|
Transitional Mesothelioma and Artificial Intelligence: Do We Need One More Subtype? and Do We Need Computers to Identify Them?
|
Academic Article
|
Tumour predisposition and cancer syndromes as models to study gene-environment interactions.
|
Academic Article
|
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.
|
Academic Article
|
Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
|
Academic Article
|
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
|
Academic Article
|
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
|
Academic Article
|
Lipid metabolism offers anticancer treatment by regulating ferroptosis.
|
Academic Article
|
Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic Perspectives.
|
Academic Article
|
This special volume of mesothelioma is dedicated to my friend Adi Gazdar.
|
Academic Article
|
SV40 and human mesothelioma.
|
Academic Article
|
Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.
|
Academic Article
|
SV40 and human brain tumors.
|
Academic Article
|
Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation.
|
Academic Article
|
High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers.
|
Academic Article
|
Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation.
|
Academic Article
|
Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40.
|
Academic Article
|
Gene expression profiles predict survival and progression of pleural mesothelioma.
|
Academic Article
|
Pathogenesis of malignant mesothelioma.
|
Academic Article
|
Malignant pleural mesothelioma.
|
Academic Article
|
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
|
Academic Article
|
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey.
|
Academic Article
|
Mesothelioma.
|
Academic Article
|
Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen?
|
Academic Article
|
A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
|
Academic Article
|
Evidence of an important role for SV40 in mesothelioma.
|
Academic Article
|
Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).
|
Academic Article
|
Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
|
Academic Article
|
SV40 detection in human tumor specimens.
|
Academic Article
|
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
|
Academic Article
|
Cellular and molecular parameters of mesothelioma.
|
Academic Article
|
Spindle cell tumors of the pleura: differential diagnosis.
|
Academic Article
|
The pathogenesis of mesothelioma.
|
Academic Article
|
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes.
|
Academic Article
|
The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
|
Academic Article
|
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
|
Academic Article
|
Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.
|
Academic Article
|
The relationship between simian virus 40 and mesothelioma.
|
Academic Article
|
The legacy of "miracle mineral": asbestos and cancer.
|
Academic Article
|
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
|
Academic Article
|
A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
|
Academic Article
|
Mesothelioma epidemiology, carcinogenesis, and pathogenesis.
|
Academic Article
|
Genomic events associated with progression of pleural malignant mesothelioma.
|
Academic Article
|
A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells.
|
Concept
|
Brain Neoplasms
|
Concept
|
Colonic Neoplasms
|
Concept
|
Kidney Neoplasms
|
Concept
|
Lung Neoplasms
|
Concept
|
Neoplasms
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Pancreatic Neoplasms
|
Concept
|
Peritoneal Neoplasms
|
Concept
|
Pleural Neoplasms
|
Concept
|
Skin Neoplasms
|
Concept
|
Uterine Neoplasms
|
Concept
|
Uveal Neoplasms
|
Concept
|
Choroid Plexus Neoplasms
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Neoplasms, Cystic, Mucinous, and Serous
|
Concept
|
Cancer Vaccines
|
Concept
|
National Cancer Institute (U.S.)
|
Concept
|
Early Detection of Cancer
|
Grant
|
University of Hawaii Cancer Center CCSG
|
Grant
|
Influence of germline mutations on susceptibility to environmental carcinogens
|
Grant
|
Mechanisms of BAP1 activity in human cancer development
|
Grant
|
Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection
|
Grant
|
Pathogenesis of mesothelioma
|
Academic Article
|
Modern criteria to establish human cancer etiology.
|
Academic Article
|
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Mesothelioma Biomarkers: Discovery in Search of Validation.
|
Academic Article
|
Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For.
|
Academic Article
|
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
|
Academic Article
|
Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review.
|
Academic Article
|
Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy.
|
Academic Article
|
Does the Amount of Asbestos Exposure Influence Prognosis?
|
Academic Article
|
Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?
|
Academic Article
|
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma.
|